글로벌 심장 마커 신속 검사 및 진료 시점(POC) 시장 – 2030년까지의 산업 동향 및 예측

심장 마커 신속 검사 및 진료 시점(POC) 시장 분석 및 규모

글로벌 심장 마커 신속 검사 및 진료 시점(POC) 시장은 전 세계적으로 심혈관 질환(CVD)의 유병률이 증가함에 따라 의료 산업 내에서 중요한 부문입니다. 이러한 검사는 심장 관련 질환을 신속하게 진단하고 즉각적인 의료 개입을 가능하게 하며 생명을 구하는 데 중요합니다. 전 세계 인구가 고령화되고 심장 질환의 발생률이 증가함에 따라 진료 시점에서 신속하고 정확한 심장 마커 검사에 대한 수요가 크게 증가했습니다.

Data Bridge Market Research는 2022년에 1억 3,746만 달러였던 글로벌 심장 마커 신속 검사 및 진료 시점(POC) 시장이 2030년까지 1억 3,000만 달러에 도달할 것으로 예상되며, 2023년에서 2030년까지의 예측 기간 동안 13.6%의 CAGR을 보일 것으로 분석했습니다. "트로포닌 신속 검사 및 진료 시점 검사는 심혈관 질환 발생률이 증가함에 따라 글로벌 심장 마커 신속 검사 및 진료 시점(POC) 시장의 유형 세그먼트를 지배하고 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

심장 마커 신속 검사 및 진료 시점(POC) 시장 범위 및 세분화

Market Definition

Cardiac markers rapid tests and point of care (POC) diagnostics refer to medical tests conducted near the patient, usually at the bedside, doctor's office, clinic, or home, to swiftly detect specific biomarkers associated with cardiovascular diseases (CVDs). These biomarkers, also known as cardiac markers, include proteins, enzymes, and other molecules released into the bloodstream in response to heart-related conditions such as heart attacks, myocardial infarction, or other cardiac events.

Global Cardiac Markers Rapid Tests and Point of Care (POC) Market Dynamics

Drivers

• Increasing Cardiovascular Diseases (CVDs) Prevalence

The rising incidence of cardiovascular diseases globally, including heart attacks and strokes, drives the demand for rapid cardiac markers tests. Early diagnosis and monitoring are crucial, leading to increased market demand.

• Growing Aging Population and Rise in Diseases

The aging population, and the prevalence of cardiovascular diseases increases. The elderly are more prone to heart related issues, necessitating regular cardiac marker testing, thus driving the market growth.

• Advancements in Point of Care Technology

Continuous technological advancements, such as portable and user-friendly POC devices, enhance the accessibility and accuracy of cardiac marker tests. Improved technology encourages adoption, driving market expansion.

• Demand for Rapid Results and Immediate Treatment

Rapid cardiac marker tests provide quick results, allowing for immediate medical intervention if necessary. Hospitals and emergency settings increasingly rely on these rapid tests to make timely decisions, fueling market growth.

Opportunities

• Home Based Reliable Testing Kits

The development of reliable home based cardiac marker testing kits provides a significant market opportunity. With a shift toward self-monitoring, convenient and accurate home testing kits are in demand, especially among individuals with a history of heart diseases.

• Integration of Biomarkers and Advanced Technologies

Integrating multiple cardiac biomarkers and utilizing advanced technologies such as biosensors and wearable devices opens opportunities for more comprehensive and real-time cardiac health monitoring, expanding the market scope.

Restraints/Challenges

• Regulatory and Approval Challenges

Stringent regulatory approval processes for new cardiac marker tests pose a challenge. Meeting regulatory standards and obtaining approvals can be time-consuming and resource-intensive, hindering market entry.

• Limited Sensitivity and Specificity of Tests

Some rapid tests may have limitations in terms of sensitivity and specificity. False-positive or false-negative results can lead to misdiagnosis or delayed treatment, impacting the reliability of these tests.

• Competition from Established Diagnostic Methods

Traditional diagnostic methods such as laboratory-based tests and imaging techniques are well-established. Convincing healthcare providers and professionals to shift from proven methods to rapid tests presents a challenge.

• Cost Constraints and Reimbursement Issues

Cost constraints, both for healthcare providers and patients, impact the adoption of cardiac marker tests. In addition, reimbursement challenges in various healthcare systems can limit market growth.

This global cardiac markers rapid tests and point of care (POC) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global cardiac markers rapid tests and point of care (POC) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Cardiac Markers Rapid Tests and Point of Care (POC) Market Scope

The global cardiac markers rapid tests and point of care (POC) market is segmented on the basis of products, surgery, end-user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Type

• Troponin Rapid Tests and Point Of Care Testing
• Brain Natriuretic Peptide (BNP) Rapid Tests and Point Of Care Testing
• Other Cardiac Markers Rapid Tests and Point Of Care Testing

Product

• Reagents
• Instruments
• Chemiluminescence
• Immunofluorescence
• Elisa
• Immunochromatography

Testing

• Lab
• Hospital Labs
• Reference Labs
• Contract Testing Labs
• Point of Care

End-Users

• Professional Diagnostic Centers
• Hospitals/Critical Care Centers
• Home Care Settings
• Research Laboratories
• Others

Global Cardiac Markers Rapid Tests and Point of Care (POC) Market Regional Analysis/Insights

The global cardiac markers rapid tests and point of care (POC) market is analysed and market size insights and trends are provided by country, products, surgery, end-users, and distribution channel as referenced above.

The countries covered in the global cardiac markers rapid tests and point of care (POC) market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the global cardiac markers rapid tests and point of care (POC) market due to high adoption rate of advanced technology and the presence of skilled professionals within the region.

Asia-Pacific is expected to show a rapid and lucrative growth rate in the global cardiac markers rapid tests and point of care (POC) market during the forecast period of 2023 to 2030 owing to the growing foreign direct investments, increase in disposable incomes and rising awareness about advanced and minimally invasive surgical techniques in patients.

The country section of the market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. The market is analysed and market size insights and trends are provided by country, product, indication and end user as referenced above.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

글로벌 심장 마커 신속 검사 및 진료 시점(POC) 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 글로벌 심장 마커 신속 검사 및 진료 시점(POC) 시장을 위한 다양한 종류의 제품 설치 기반, 수명선 곡선을 사용하는 기술의 영향, 의료 규제 시나리오의 변화 및 글로벌 심장 마커 신속 검사 및 진료 시점(POC) 시장에 미치는 영향. 이 데이터는 2015-2020년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 글로벌 심장 마커 신속 검사 및 진료 시점(POC) 시장 점유율 분석

글로벌 심장 마커 신속 검사 및 진료 시점(POC) 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 글로벌 심장 마커 신속 검사 및 진료 시점(POC) 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 심장 마커 신속 검사 및 진료 시점(POC) 시장에서 운영되는 주요 업체는 다음과 같습니다.

• 애벗(미국)
• F. 호프만-라 로슈 유한회사(스위스)
• 지멘스 헬스케어 프라이빗 리미티드(독일)
• Beckman Coulter, Inc. (미국)
• BD(Becton, Dickinson and Company) (미국)
• 존슨앤존슨 서비스 주식회사(미국)
• 계측 실험실(미국)
• PTS 진단(미국)
• 아바시스(미국)
• 메드트로닉(아일랜드)
• Opti Medical(미국)
• 시엔코 주식회사(미국)
• Alpha Scientific Electronics(대만)
• AccuBioTech Co., Ltd. (중국)
• ACON 연구소, Inc. (미국)
• bioMérieux, Inc. (프랑스)
• Ortho Clinical Diagnostics (미국)
• Randox Laboratories Ltd. (영국)

SKU-52354